142 related articles for article (PubMed ID: 18236229)
1. Biomarkers of low-level exposure to soman vapor: comparison of fluoride regeneration to acetylcholinesterase inhibition.
Dabisch PA; Davis EA; Renner JA; Jakubowski EM; Mioduszewski RJ; Thomson SA
Inhal Toxicol; 2008 Jan; 20(2):149-56. PubMed ID: 18236229
[TBL] [Abstract][Full Text] [Related]
2. Assessment of low level whole-body soman vapor exposure in rats.
Genovese RF; Benton BJ; Johnson CC; Jakubowski EM
Neurotoxicol Teratol; 2009; 31(2):110-8. PubMed ID: 19026741
[TBL] [Abstract][Full Text] [Related]
3. Inhalation toxicity of soman vapor in non-anesthetized rats: a preliminary assessment of inhaled bronchodilator or steroid therapy.
Perkins MW; Wong B; Rodriguez A; Devorak JL; Alves DA; Murphy G; Sciuto AM
Chem Biol Interact; 2013 Dec; 206(3):452-61. PubMed ID: 23886498
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and behavioral effects of soman vapors in low concentrations.
Bajgar J; Sevelová L; Krejcová G; Fusek J; Vachek J; Kassa J; Herink J; de Jong LP; Benschop HP
Inhal Toxicol; 2004 Jul; 16(8):497-507. PubMed ID: 15204741
[TBL] [Abstract][Full Text] [Related]
5. Low level nose-only exposure to the nerve agent soman: toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs.
Benschop HP; Trap HC; Spruit HE; Van Der Wiel HJ; Langenberg JP; De Jong LP
Toxicol Appl Pharmacol; 1998 Dec; 153(2):179-85. PubMed ID: 9878589
[TBL] [Abstract][Full Text] [Related]
6. Validation and application of a GC-MS method for determining soman concentration in rat plasma following low-level vapor exposure.
Renner JA; Dabisch PA; Evans RA; McGuire JM; Totura AL; Jakubowski EM; Thomson SA
J Anal Toxicol; 2008; 32(1):92-8. PubMed ID: 18269800
[TBL] [Abstract][Full Text] [Related]
7. Vapor inhalation exposure to soman in conscious untreated rats: preliminary assessment of neurotoxicity.
Perkins MW; Wong B; Rodriguez A; Devorak JL; Dao TT; Leuschner JA; Kan RK; Sciuto AM
Inhal Toxicol; 2016; 28(1):14-21. PubMed ID: 26711353
[TBL] [Abstract][Full Text] [Related]
8. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
[TBL] [Abstract][Full Text] [Related]
9. Formation of soman (1,2,2-trimethylpropyl methylphosphonofluoridate) via fluoride-induced reactivation of soman-inhibited aliesterase in rat plasma.
de Jong LP; van Dijk C
Biochem Pharmacol; 1984 Feb; 33(4):663-9. PubMed ID: 6704183
[TBL] [Abstract][Full Text] [Related]
10. Biochemical effects of low level exposure to soman vapour.
Bajgar J; Sevelová L; Krejcová G; Fusek J; Vachek J; Kassa J; Herink J; de Jong LP; Benschop H
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S4-7. PubMed ID: 15141961
[TBL] [Abstract][Full Text] [Related]
11. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor.
Langenberg JP; Spruit HE; van der Wiel HJ; Trap HC; Helmich RB; Bergers WW; van Helden HP; Benschop HP
Toxicol Appl Pharmacol; 1998 Jul; 151(1):79-87. PubMed ID: 9705889
[TBL] [Abstract][Full Text] [Related]
12. Gas chromatography-tandem mass spectrometry analysis of red blood cells from Göttingen minipig following whole-body vapor exposure to VX.
Byers CE; McGuire JM; Hulet SW; Burnett DC; Gaviola BI; Jakubowski EM; Thomson SA
J Anal Toxicol; 2008; 32(1):57-62. PubMed ID: 18269794
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic receptor dysfunction induced by exposure to low levels of soman vapor.
Dabisch PA; Horsmon MS; Muse WT; Mioduszewski RJ; Thomson S
Toxicol Sci; 2007 Nov; 100(1):281-9. PubMed ID: 17693423
[TBL] [Abstract][Full Text] [Related]
14. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats.
Mioduszewski R; Manthei J; Way R; Burnett D; Gaviola B; Muse W; Thomson S; Sommerville D; Crosier R
Toxicol Sci; 2002 Apr; 66(2):176-84. PubMed ID: 11896284
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to the miotic effect of sarin vapor in rats after multiple low-level exposures.
Dabisch PA; Burnett DC; Miller DB; Jakubowski EM; Muse WT; Forster JS; Scotto JA; Jarvis JR; Davis EA; Hulet SW; Reutter SA; Mioduszewski RJ; Thomson SA
J Ocul Pharmacol Ther; 2005 Jun; 21(3):182-95. PubMed ID: 15969635
[TBL] [Abstract][Full Text] [Related]
16. Blood and bronchoalveolar lavage fluid acetylcholinesterase levels following microinstillation inhalation exposure to sarin in Guinea pigs.
Che MM; Conti M; Boylan M; Sciuto AM; Gordon RK; Nambiar MP
Inhal Toxicol; 2008 Jul; 20(9):821-8. PubMed ID: 18645722
[TBL] [Abstract][Full Text] [Related]
17. Acute respiratory toxicity following inhalation exposure to soman in guinea pigs.
Perkins MW; Pierre Z; Rezk P; Sabnekar P; Kabra K; Chanda S; Oguntayo S; Sciuto AM; Doctor BP; Nambiar MP
Toxicol Appl Pharmacol; 2010 Jun; 245(2):171-8. PubMed ID: 20206646
[TBL] [Abstract][Full Text] [Related]
18. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and biochemical evaluation of sub-lethal inhalation exposure to VX in rats.
Genovese RF; Benton BJ; Lee EH; Shippee SJ; Jakubowski EM
Toxicology; 2007 Mar; 232(1-2):109-18. PubMed ID: 17234319
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
